| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.037 | 0.8 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |